v t Regional blood flow (BF) was measured in RT-9 experimental brain tumors using carbon-14 labeled iodoantipyrine, the Kety tissue-exchange equations, and quantitative autoradiographic techniques. Blood flow was variable within tumor tissue, and the range of BF increased with increasing tumor size; the overall range was 6 to 138 ml/100 gm/min and the maximum range within an individual tumor was 55 ml/100 gm/min. In all but one case, mean tumor BF was less than that in the same anatomic region of the contralateral hemisphere (CBA). The magnitude of BF within individual tumor foci generally could be related to tumor size, location (intraparenchymal versus extraparenchymal), and the presence of necrosis or cysts; it was lower in the geometric centers than in the periphery of medium-sized and large tumors. Brain adjacent to tumor had higher BF's than the tumor periphery; generally, the BF in the brain adjacent to the tumor was less than that in the CBA. A global depression of BF was observed within tumor-free cortex and corpus callosum of the hemisphere ipsilateral to tumor implantation and primary growth, suggesting a hemispheric reduction in metabolic and functional activity. KEY WORDS 9 blood flow 9 RT-9 brain tumor 9 quantitative autoradiography 9 iodoantipyrine 9 experimental tumor model E FFECTIVE brain tumor chemotherapy must consider the delivery of drugs and metabolites to the tumor cells. The initial transport steps involve blood flow (BF) through the tumor microvasculature and the exchange rate of drugs and metabolites across the blood-tissue interface. Recent reviews of transcapillary transport within the central nervous system (CNS) 5-7,~5,3~ emphasize the complex nature of transendothelial distribution of solutes and drugs. The patterns of distribution within tumor tissue, as well as those in brain, are a function of the extent of binding and/or uptake of the drug by blood cells and plasma proteins, the flow of blood to the tissue, the permeability-surface area product of the vessels to the particular drug or substrate, and their distribution volume(s) within the tissue. Therefore, the initial access of pharmacologically active agents to tumor cells could be partially or completely limited by low BF.
hole drilled 2 mm to the right of the sagittal suture and 3.5 mm anterior from the lamdoidal suture. A blunt needle 3 mm in length attached to a 0.1-ml Hamilton syringe was sterilized and used for inoculation. The hole was immediately sealed with sterile bone wax. Approximately 1% to 2% of the animals died under anesthesia during the injection of tumor cells. Subcutaneous tumor growth, presumably due to reflux of the inoculated cell suspension, was observed in 10% to 20% of the animals. Blood flow experiments were carried out 18 to 21 days after injection of tumor cells.
The animals were anesthetized with a halothanenitrous oxide-oxygen mixture (1.5:70:30, v/v/v). Bilateral femoral artery and vein catheters were inserted and a single extracorporeal arteriovenous shunt was formed on the left side with a 3-cm length of silicone rubber tubing to facilitate rapid arterial blood sampling. The animals were allowed to recover from anesthesia for 2 to 3 hours; body temperature was continuously monitored and maintained at 35 ~ to 37~ using heat lamps. Arterial blood pressure, pO2, pCO2, and pH were monitored during the recovery period and just prior to or during the experiments; the values were: 104 _ 4 (SEM) mm Hg, 98 -4-5 torr, 36.1 + 1.1 torr, and 7.40 + 0.05, respectively.
Experimental Procedures
Regional BF was measured using carbon-14 labeled iodoantipyrine Q4C-IAP, 4-[N-methyl-14C], 40 to 60 mCi/mmol), as previously described. *s,4~ Isotopic purity was determined by chromatography in two solvent systems, ~9 and more than 97% of the radioactivity was localized to the appropriate chromatographic region.
An injection of 40 gCi of 14C-IAP in 1 cc saline (after ethanol evaporation) was administered into the right femoral vein over 35 seconds, according to an increasing infusion schedule which resulted in continuously increasing blood levels. Serial 5-second arterial blood samples were obtained and plasma radioactivity was measured by beta liquid scintillation counting in a Beckman LS 350 liquid scintillation spectrometer using external standard quench corrections. The animal was decapitated at 30 seconds and the brain was rapidly extracted (usually within 1 minute), frozen in liquid freon cooled to -40~ dipped in embedding matrix, tightly wrapped in a plastic freezing bag, and stored at -80~ prior to sectioning, s
Quantitative A utoradiography and Histology
Tissue sections were prepared for histology and quantitative autoradiography as described previously, s,35 Briefly, the brains were mounted on planchets and eight serial sections were cut 20 /t thick * 14C-iodoantipyrine obtained from New England Nuclear Corp., Boston, Massachusetts. R. G. Blasberg, et al. at -20~ in a cryomicrotome at intervals of 400 to 600/~. Sections 1, 2, 7, and 8 were placed on microscopic glass slides and processed for histology. Sections 3 through 6 were placed on glass coverslips, rapidly dried, mounted on cardboard, and placed in a cassette with 14C-methylmethacrylate standards which previously had been calibrated to reference 20-/~ thick brain sections of known radioactivity. Singlecoated x-ray fllmt was positioned over the sections and standards for a 6-week period of exposure. To convert the x-ray film images to tissue radioactivity (nCi/gm), the optical densities of the images produced by the 14C standards were measured, and a standard curve which related optical density to tissue radioactivity was generated for each film. Sequential measurements of optical density within 50 • 50-# elements of the tissue autoradiographic image were made using a computerized high-speed microdensitometer.~: The optical density data were stored by the computer,w and could be converted to radioactivity using the standard curve described above and displayed on a video monitor using an image array processor;ll this was achieved by a system similar to that described by Goochee, et al. 18
Calculations and Measurements
The calculation of BF in these studies depends on the application of a working equation developed by Kety:26, 27 Ci(T) = Xk C,(t)e-klT'tldt,
where Ci(T) is the tissue concentration of radioactive IAP as determined by quantitative autoradiography at a given time, T, after introducing the tracer into the circulation; X is the tissue:blood partition coefficient; Ca is the concentration of the tracer in arterial blood; and t is the variable time. Equation 1 is solved for k using the experimentally determined data for the other variables; k equals a constant that incorporates the rate of BF in the tissue as follows:
In Equation 2, F is the rate of blood flow per unit mass of tissue and m is a constant that has a value between 0 and 1 and represents the extent to which diffusional equilibrium between blood and tissue is achieved by the marker material during its passage from the arterial to the venous end of the capillary. Based on the work of Sakurada, et al., 41 m was taken J-Single-coated x-ray f'tlm, MR-1, obtained from Kodak, Rochester, New York.
~: Microdensitometer, P-10000 HS, manufactured by Optronics International, Inc., Chelmsford, Massachusetts.
w Computer, PDP 11/60, RK07, manufactured by Digital Equipment Corp., Maynard, Massachusetts.
[1 Image array processor, IP-5000, manufactured by DeAnza Systems, Inc., Santa Clara, California.
to be equal to 1.0 and ), was found to be equal to 0.8 for IAP. The value of 2~ for IAP in five avian sarcoma virus-induced brain tumors varied between 0.87 and 1.2. 9 It can be shown that this range of variation in results in negligible errors in the value of F calculated with Equations 1 and 2 for a 30-second experiment, la
Regional measurements of BF were obtained using a computer-controlled cursor-outlining routine on the video monitor that could outline selected tissue areas for measurement. The autoradiographic and histological images from adjacent tissue sections were projected on separate monitors. A grid-overlay matching routine was used to identify and outline specific areas for regional tissue measurements. The results were expressed as the mean and standard deviation of all individual measurements within the defined area. Whole-tumor measurements are given by the average of all measurements within the histologically defined tumor cross-sectional area; low and high values represent the range of variation within the tumor, which is also indicated by the standard deviation of the whole tumor measurements. Central tumor measurements are the average of all measurements within the central region of the tumor; peripheral tumor measurements are the average of all remaining measurements which are taken within the peripheral region of the tumor. The ratio of central to whole-tumor area ranged between 0.8 and 0.9:1. The brain adjacent to tumor (BAT) involved in arbitrary narrow rim of brain tissue, 200 to 300/, wide, around the tumor. The interface between tumor and BAT outlined the main mass of the neoplastic tissue. Due to the highly infiltrative character of the tumor, scattered solitary and small foci of tumor cells were present in variable amounts within the BAT. Measurements of BF were made in brain regions with a similar cross-sectional area and location in the hemisphere contralateral to the tumor; the mean value and standard deviation are presented.
Results

Gross Patterns and Histological Characteristics of Tumor Growth
Injection of the tumor cell suspension usually resulted in a significant tumor mass and symptomatic animals (weight loss, lethargy, focal motor impairments) within 15 to 18 days. A small, somewhat globoid, tumor mass usually developed by the 10th day after injection. Subsequently, infiltration of the surrounding brain parenchyma (Figs. 1 to 3 ) occurred in three identifiable patterns. One was a random pattern that could not be correlated to specific anatomical structures, such as blood vessels or whitematter tracts. In the second, infiltration occurred along perivascular spaces resulting in "tongues" of tumor tissue that frequently formed collars of variable thickness around blood vessels and often developed into secondary loci of tumor growth (Fig. 3) . No The third mode of tumor propagation occurred along the needle track and resulted in seeding of the cerebrospinal fluid (CSF) with intraventricular and subarachnoid tumor growth. Intraventricular tumor growth was always associated with invasion of the choroid plexus. Subarachnoid growth was usually extensive when present. The extracerebral propagation of tumor frequently resulted in a localized mass or a dumbbell-shaped tumor which was contiguous with the needle track and tumor mass at the injection site. Usually the extracerebral tumor was large and compressed adjacent cortex; however, reactive astrocytic proliferation was not observed in the adjacent brain tissue. In addition, extensive extracerebral tumor propagation sometimes occurred along subarachnoid pathways and within meningeal tissue, which resulted in a thin tumorous mantle that covered a large surface of the brain. A similar pattern of tumor extension into brain fissures and sulci (that is, hippocampal sulcus) was frequently observed in these animals. Although extensive subarachnoid propagation of tumor was observed in only one of the six animals in this study (Experiment 4), it was prominent in four of eight animals in the subsequent study ? 3 Reinvasion of the brain parenchyma from subarachnoid and meningeal tumor along the VirchowRobin spaces of superficial penetrating blood vessels was present in some animals. Ventricular seeding of tumor cells and subsequent invasion of choroid plexus may have occurred at the time of injection. This pattern of tumor spread and localization was seen only in Experiment 3, but it was present in five of eight animals in the subsequent studyY
The tumors were generally cellular and exhibited moderate to extensive pleomorphism with round or oval nuclei, diffuse chromatin, and variable numbers of mitoses (Fig. 2) . Cellular pleomorphism was expressed by highly anaplastic, fibrillary, or sarcomatous characteristics. Most tumors included elongated spindle-shaped cells that were grouped together in whorled bundles or were diffusely scattered between anaplastic astrocyte-like tumor cells. In a few cases, large areas and occasionally almost the entire tumor was composed of these sarcoma-like cells. Regressive tumor changes and cellular rarefaction due to early necrosis were infrequently observed within small and medium-sized intraparenchymal tumors. Irregularly shaped necrotic foci surrounded by abortive pseudopallisade formation and cystic degeneration were occasionally observed in the larger tumors, usually in their extraparenchymal-subdural extensions.
Blood Flow
Quantitative assessments of regional BF were made in six animals, and included 18 independent or semiindependent tumor foci. The largest cross-sectional area of a given tumor focus was found to present a representative pattern of BF for the entire focus. This was determined by sequential analysis of the histological and autoradiographic sections cut along the tumor's rostrocaudal axis in several experiments. The lower limit of reliable optical density measurements above x-ray film background in these studies corresponded to a BF of 1 to 5 ml/100 gm/min.
Small lntraparenchymal Tumors
The mean BF in small tumors (maximum crosssectional area less than 2 sq mm) was approximately 85% of that in the corresponding contralateral brain region (Table 1 ). In only one case was the mean BF in a tumor higher than that in the surrounding or contralateral brain tissue; this tumor was growing in the anterior commissure (Tumor lc, Table 1 ). However, this relationship was not observed in another tumor composed of small groups of infiltrating cells that had invaded the corpus callosum and cingulum (Tumor 2a, Table 1 ). Blood flow varied in the small tumors as indicated by the range of their high and low values and the standard deviation of mean tumor values ( Table 1 ). The brain adjacent to these small tumors (BAT) usually had a slightly higher BF than the tumor.
Medium and Large lntraparenchymal Tumors
The medium and large size intraparenchymal tumors had considerable regional differences in BF within the tumor mass (Figs. 4 to 6, Table 2 ). Central tumor regions consistently had lower mean BF's in comparison to the average BF measured in the whole tumor and to that in more peripheral tumor regions. The range of BF within these tumors is indicated by their high-low values and the standard deviation of the mean tumor value.
The rim of brain tissue adjacent to this group of tumors always had higher BF than the peripheral tumor region (Fig. 4) . This observation is not dearly indicated by a comparison of BAT with the "mean" or "periphery" tumor BF values given in Table 2 , because BAT represents an average BF value around the whole tumor (Tables 1 to 3 ). In two animals, BF was slightly higher in the BAT than in the correspondhag contralateral brain area (Tumors 1 e and lf, Table  2 ). Similarly, mean blood flow was greater in contralateral brain tissue than in all medium and large size tumors, except one (Tumor le, Table 2 ).
Extracerebral Tumors
Tumor grew back along the needle track and over the convexity of the brain in four animals (Fig. 5) . Average tumor BF in this group (Table 3) was slightly less than in similar sized intraparenchymal tumors (Table 2) . Sarcomatous changes were more prominent in extracerebral tumors. Apart from this observation and tumor size, no evidence for a relationship between histology or cytology and BF was identified. Regional variability of BF within this group of tumors was also observed (Fig. 5) , as indicated by the range of their high-low values and the standard deviation of the mean values (Table 3 ). The central-peripheral differences in regional tumor BF were less striking for extracerebral tumors in comparison to those for intraparenchymal tumors of similar sizes (Tables 2 and 3) . The values of BF in the BAT, which represents cortical areas adjacent to tumor growing over the hemisphere, were considerably greater than those of the tumor and considerably less than those in the corresponding contralateral brain region in two animals in which such measurements were possible (Table 3) .
Regional Tumor and Brain Comparisons
Regional tumor BF measurements ranged between 6 and 106 ml/100 gm/min in the 18 tumors that were studied. A somewhat narrower range of BF was noted in the individual tumor groups (Tables 1 to 3) ; the maximum range for an individual tumor was 55 ml/ 100 gm/min. The mean value of BF in a tumor was usually less than that calculated for the peripheral Table 4 . Blood flow was consistently lower in structures o f the hemisphere ipsilateral to the tumor; this difference was more apparent in the parietal cortex than in the corpus callosum.
Discussion
There has been considerable debate about the relevance o f experimentally generated C N S tumors as representative models for studying pathophysiology and chemotherapy o f brain neoplasia. As noted by Rubinstein, 39 the demonstration o f histological similarities to h u m a n brain tumors has often been considered to be an important criterion for validation o f a
Fro. 6. Left: Macroscopichistologicalsection demonstrating Tumor 4b in the putamen.H & E. Right:
Corresponding image of regional blood flow color-coded to a range of specific values. Note the wide range of blood flow in this large tumor; regional variations in flow do not correlate with specific histological features such as tumor necrosis, cell density, or tissue vascularity. particular experimental model. However, in addition to histological variability, cytogenic, biochemical, and immunological heterogeneity have also been found in both experimental and human primary brain tumors.l,4.4s The histological variability of human brain tumors that led to our current classifications, and the more recent demonstration of other forms of tumor heterogeneity, suggest that the search for an "ideal" experimental brain-tumor model may be an unrewarding goal. Comparisons between various tumor models may be more useful and demonstrate a range of observations with respect to tumor biology and response to therapy that are more likely to be representative of the actual human condition. The RT-9 tumor model was originally produced in 12-week-old CD Fischer 344 rats given 36 weekly injections of 5 mg/kg N-nitrosomethylurea2 Although the RT-9 and related 9L experimental tumor models cannot be considered "ideal," there are several features that account for their widespread use. According to Barker, et al.,2 the morphology of the tumor ceils in culture is quite similar to that of human astrocytes. Benda, et al., 3 concluded that MNU-induced gliomas continue to synthesize glial-specific S-100 protein for a considerable length of time. It is obvious, however, that long-term tissue culture results in significant changes of the characteristics of a given tumor. 46 Despite all the difficulties in defining the histogenetic origin of the spindle-cell and sarcomatous elements in the RT-9 and 9L tumors, the overall histological picture resembles the so-called mixed (glial plus mesenchymal) tumors of the human nervous system. The rapidly invasive characteristics of intraparenchymal tumor growth of the RT-9 model are also observed in human neuro-oncology with the higher grade gliomas. The prominent subarachnoid spread of tumor observed in one of our animals probably reflects the reflux of tumor cells along the R. G. Blasberg, et al. needle track and seeding of the subarachnoid space more than a specific characteristic of RT-9 tumor growth. Nevertheless, prominent subarachnoid expansion has been observed in some cases of human glioma. 4o
Regional Blood Flow in Tumor
Blood flow within the 18 RT-9 tumor foci was variable (Figs. 4 to 6, Tables 1 to 3) ; the maximum range of BF within an individual tumor was 55 ml/ 100 gm/min. The intratumoral variation of BF was more prominent in the larger tumors, and lower values were generally measured centrally in comparison to peripheral tumor regions. A similar central-to-peripheral BF gradient was demonstrated by Hossmann, et aL, 2~ in their medium and large size gliomas; these tumors developed from ceils cloned from a nitrosourea-induced malignant glioma and injected into the brain. In contrast, Yamada, et aL, 47 observed the opposite relationship in their medium-sized (2 to 4 mm in diameter) ethylnitrosourea (ENU)-induced gliomas; central tumor regions had higher BF's than peripheral regions. Similar but not identical regional BF measurements have been reported in other braintumor models. 19,2~ A constant feature in all these studies has been regional variability of BF in the tumors.
Blood flow was uniformly low in regions of necrosis, but the lowest values of BF did not necessarily correspond to necrotic tissue (Fig. 6) . In fact, one study has reported a very high BF in viable-appearing tissue surrounding necrotic tumor regions. 47 Small foci of hyperemia in another study, 23 although rarely observed, were associated with the infiltrative rim of the tumor or adjacent brain tissue but a specific correlation with vascular density, mitotic activity, size, or other histological characteristics of the tumor could not be established. The histological appearance of a particular tumor region frequently did not provide an explanation for either a maximum or minimum BF value in this study.
The magnitude of BF above which necrosis was not observed (namely, the "critical flow") was quite variable in a preliminary comparison of different tumor models? Although tumor size influenced the magnitude of mean BF measurements (Tables 2 to 4), the regional variation in BF and irregular location of necrotic foci call attention to the need for reevaluating the classical concept of "critical mass" for the explanation of tumor necrosis. The growth of the tumor mass, the functional adequacy of its supplying vessels, and the metabolic requirements for tumor viability seem to have a complex relationship with one another. The development of tumor necrosis is likely to reflect a particular and critical level of metabolism in relationship to the availability of substrates and the clearance of metabolites. Inasmuch as BF determines availability and clearance of metabolites, the concept of "critical flow" is appropriate in a discussion of tissue necrosis and is likely to be variable within different regions of a given tumor as well as for different tumors and tumors growing in different locations.
Almost all of the tumors studied in this series seemed to have been well supplied with blood vessels. In contrast, Heinicke 21 has suggested that vascularization of tissues transplanted into the brain depends more on the characteristics of the tissue transplanted than on host tissue factors. This may explain the differences between the vessels of this originally MNU-induced tumor and those of the ENU-induced neoplasms studied by Lantos and Pilkington. 28 In addition to the data presented in Tables 2 to 4 , blood flow was measured in two tumor foci associated with choroid plexus. F in the smaller tumor was 66 + 21 ml/100 gm/min, whereas, it was 18 +__ 3 ml/100 gm/ min in the larger tumor mass. These observations plus other data presented in this study suggest that tumor tissue, whether by metabolic demands or other factors, can alter blood flow from that of the host tissue. Evidently, tumor factors as well as host tissue factors have an important role in influencing blood flow and growth of the neoplasm.
Regional Blood Flow in Brain
Blood flow in BAT was generally higher than that of the tumor. The magnitude of the difference in BF between tumor and BAT generally increased with tumor size. The influence of scattered small tumor foci, mostly solitary cells infiltrating BAT, on the magnitude of BF within this tissue region is difficult to assess because the extent of tumor cell infiltration was quite variable. Clearly, a marked effect was not observed. Similarly, BF in the tumor-free hemisphere within structures corresponding to the same areas harboring the tumor, was generally higher than that of the tumor itself. However, contralateral hemisphere BF values in areas corresponding to the tumor location were generally lower than the values reported by Sakurada, et al., 4~ for comparable structures in the normal awake rat. In several cases, this difference was considerable and seemed to be related to tumor size (Tables 1 to 3) .
A hemispheric as well as regional reduction in cerebral blood flow (CBF), measured 15 to 18 days after tumor cell injection, was demonstrated by these studies (Figs. 4 to 6 , Table 4 ). This hemispheric difference in mean BF of brain tissue not directly infiltrated with tumor cells was statistically significant for parietal cortex and corpus callosum (p < 0.001 and p < 0.02, respectively, paired t-test of the mean values in Table 4 ). Similar paired differences were observed in other structures (Figs. 4 to 6) . A comparison between the averaged mean values of BF in the ipsilateral and contralateral parietal cortex and corpus callosum shown in Table 4 and those of Sakurada, et al.,41 demonstrated a statistically significant reduction only for ipsilateral parietal cortex (p < 0.005, Student's t-test). Hossmann, et al., 23 reported hemispheric BF differences in the hippocampus and thalamus but not in the cortex, and in the same experimental tumor van den Kerckhoff, et al., 25 found that corticosteroids prevented depression of BF in peritumoral white matter. These observations may be due to the more central location of tumor growth in the above studies 24,25 in comparison to the tumors reported here. Hossmann, et al., ~ also found normal BF in the contralateral hemispheres of tumor-bearing cats up to 4 weeks following implantation. These hemispheric differences in regional BF are in agreement with several studies performed in humans with brain tumors.lt, 13, 14, 36, 43 Several explanations to account for the global reduction in CBF in both human subjects and experimental animals harboring brain tumors have been suggested and include increased intracranial pressure (ICP), TM disturbed autoregulation in brain adjacent to tumor and remote brain regions, 1~ and the effect of neurogenic control on CBF? 2 Our fmdings suggest a relationship between tumor size and the degree of flow reduction which implicates the effects of regional brain involvement and distortion of anatomical structures as well as increased ICP. In contrast, others do not consider increased ICP as the primary cause of reduced CBF) TM Some authors have emphasized the regular occurrence of hyperemia around human brain tumors. 22 A comparison of BF within tumor, the surrounding brain, and similar structures in the contralateralhemisphere in our experiments, as discussed above, indicates the relative character of this "hyperemia" if indeed it exists at all.
The above discussion suggests that there is a complex relationship between BF and other physiological and biochemical characteristics of intracerebral tumors. The variability in regional tumor BF is likely to reflect differences in the flow characteristics of tumor blood vessels and capillaries, regional differences in metabolism and the extracellular environment which could alter regional BF, and the presence of edema, as well as differences in growth rate between the tumor and its supporting vascular network t6,17 which could alter capillary density.
